Investing.com - Precision BioSciences reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Precision BioSciences announced earnings per share of $-0.22 on revenue of $7.36M. Analysts polled by Investing.com anticipated EPS of $-0.34 on revenue of $9.86M.
Precision BioSciences shares are down 35% from the beginning of the year and are trading at $1.26 , down-from-52-week-high.
Precision BioSciences shares gained 1.61% in intra-day trade the report.
Precision BioSciences follows other major Healthcare sector earnings this month
Precision BioSciences's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar